Chronic Effects and Biological Upshots of Cannabis Use
- đ¤ Speaker: Ronald Berger, Assistant Professor, Whitaker Biomedical Engineering Institute, School of Medicine, Johns Hopkins University
- đ Date & Time: Thursday 25 July 2013, 10:00 - 11:30
- đ Venue: Jock Colville Hall, Churchill College, University of Cambridge
Abstract
Although there are over 300 cannabinoid or cannabinoid-related compounds reported as natural constituents of Cannabis (Turner, et al., 1980) most strains of marihuana are characterized by the production of a biogenetically related series of compounds (Figure 1). Cannabinoids are terpenophenolic compounds believed to originate in the plant from condensation of a terpene derivative (such as geranyl pyrophosphate) with the phenol olivetol (as olivetolic acid) to form the cannabinoid series which includes cannabigerolic acid (CBGA), cannabichromenic acid (CBCA), cannabidiolic acid (CBDA), and Î9-tetrahydrocannabinolic acid (Î9-THCA) (Mechoulam, 1970; Shoyama, et al., 1975). These cannabinoids occur naturally predominantly in their water-soluble acid forms but are readily decarboxylated to their water-insoluble neutral forms by mild heating or drying of plant tissues or extracts.
Series This talk is part of the Cambridge University Engineering Society series.
Included in Lists
- Cambridge University Engineering Society
- Jock Colville Hall, Churchill College, University of Cambridge
Note: Ex-directory lists are not shown.
![[Talks.cam]](/static/images/talkslogosmall.gif)

Ronald Berger, Assistant Professor, Whitaker Biomedical Engineering Institute, School of Medicine, Johns Hopkins University
Thursday 25 July 2013, 10:00-11:30